Kidney StonesRIRSNCT02304822
Comparison of Multiple-, Single- and Zero-dose of Ciprofloxacin Prophylaxis in Retrograde Intrarenal Surgery
A study testing Multiple-dose of Ciprofloxacin prophylaxis, Single-dose of Ciprofloxacin prophylaxis and Zero-dose of Ciprofloxacin prophylaxis in people with Kidney Stones, run by Guohua Zeng at 1 site in China.
Trial summary
The purpose of this study is to compare the postoperative systemic inflammatory response syndrome (SIRS) rates undergoing retrograde intrarenal surgery (RIRS) after multiple-, single-, zero-dose of ceftriaxone prophylaxis in a prospective randomized trail. Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Kidney Stones
- What is being tested?
- Multiple-dose of Ciprofloxacin prophylaxis, Single-dose of Ciprofloxacin prophylaxis and Zero-dose of Ciprofloxacin prophylaxis
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 450 participants
- Where
- 1 siteChina
- Study dates
- Aug 2014to Dec 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Decision to performed RIRS to treat the kidney stones
- American society of Anesthesiology (ASA) score 1 and 2
- Kidney stones of diameter < 2.5 cm
Who cannot join
- Positive preoperative urine culture
- Pyruria (>10 white blood cells per high-power field)
- Antibiotics treatment of UTI in the last 4 weeks
- Immunocompromised
- Diabetes mellitus
- Allergy to quinolone
Show all 9Show fewer
- Existing ureteric stents
- Turbid pelvic urine or purulent stone surface observed intraoperatively
- Ureteral stricture, renal or urethral deformity
Trial locations and contacts
1 site in 1 country.
China1 site, 1 recruiting
- Recruiting
Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510230
Guohua Zeng, Ph.D and M.D, +86 13802916676, gzgyzgh@vip.tom.com
Guohua Zeng, Ph.D and M.D
About this study
Official title: Ciprofloxacin Prophylaxis in Retrograde Intrarenal Surgery: a Prospective Randomized Trail in Comparison of Multiple-, Single- and Zero-dose.
The purpose of this study is to compare the postoperative systemic inflammatory response syndrome (SIRS) rates undergoing retrograde intrarenal surgery (RIRS) after multiple-, single-, zero-dose of ceftriaxone prophylaxis in a prospective randomized trail.
The investigators will enroll 450 patients who are candidates for RIRS in the investigators study. By simple random sampling technique, patients will be assigned to three groups (multiple-, single-, zero-dose of ceftriaxone prophylaxis,respectively). In addition to the difference of usage of ciprofloxacin prophylaxis, the rest of the procedure is the same in all three groups.The end point of the study is the comparison of outcome of procedure including SIRS rate, stone free rate (SFR), operation time, length of stay,and hematuresis.
Read the detailed description
PURPOSE:
To compare multiple-, single-, zero-dose antibiotic prophylaxis for retrograde intrarenal surgery (RIRS) and detect the ideal regimen to prevent systemic inflammatory response syndrome (SIRS).
METHODS:
An α error of 5% and a power of 80% were assumed to detect a 14.9% difference in rates of postoperative SIRS (5.1% for the antibiotic prophylaxis group and 20% for the control group) based on the historical data. According to sample size calculation formula for comparing rates between multiple independent samples, n=2λ/(2sin-1√Pmax-2sin-1√Pmin)2,the minimum sample sizes to detect statistically significant differences were estimated to be 86 patients for each of the study groups. To account for patients lost to follow-up and study withdrawals, this number was increased to 100.
After finishing the cases mentioned above, we find the difference in rates of postoperative SIRS in our center is 7.9% (1.2% for the antibiotic prophylaxis group and 9.1% for the control group). According to sample size calculation formula, the minimum sample sizes were estimated to be 124, additional 38 patients are required to be added to each group. For the accuracy and availability of the trial, we decided to enlarge the sample size.To account for patients lost to follow-up and study withdrawals, this number was increased to 150.
After obtaining informed consent, the patients were assessed for eligibility. To allocate the patients, a computer-generated list of random numbers was used. The patients were randomly allocated into three groups by using a randomization ratio of 1:1:1 (group 1, multiple-dose prophylactic antibiotic of 200mg intravenous ciprofloxacin, 30 minutes before surgery and within 12 hours after surgery additionally; group 2, single-dose prophylactic antibiotic of 200mg intravenous ciprofloxacin, 30 minutes before surgery; group 3,zero-dose of prophylactic antibiotic). All patients were operated under intrathecal general anesthesia.
All operations were performed by one experienced surgeon (Guohua Zeng). The surgeon was blinded to group assignment. The postoperative clinical assessment was performed by investigators who had not been involved and were also blind of the group assignment.
Preoperative routine physical examination was performed in all patients. White blood count, blood urea nitrogen, creatinine, liver function test, urinalysis, and urine culture were investigated. Before surgery, stone size and location were determined by choosing at least one of following imaging methods: intravenous pyelography (IVP), kidney, ureter, and bladder (KUB),or unenhanced CT. Inclusion Criteria and exclusion Criteria were shown in the part of "eligibility Criteria".
All equipment used during operation was chosen from the same brand, and standard sterilization procedures were applied. In this study, the investigators used SIRS criteria defined by the committee for consensus on the definition of sepsis, in order to define postoperative fever in a better way. Patients were followed postoperatively according to SIRS criteria: white blood count < 4000 or >12000 cells/mm3, heart rate >90 beats per minute, temperature <36°C or >38°C, respiratory rate > 20 breaths/min. Presence of two or more of these criteria was accepted as SIRS.
RIRS technique :All the endourological procedures in the present study were performed in a standard suite, and a sterile technique was strictly practiced and maintained in all cases. All RIRS procedures were performed under general anesthesia in a low lithotomy position. Ureteroscopy was performed with a semi-rigid 8/9.8Fr ureteroscope (Richard Wolf, Germany), and a flexible 0.035-inch guide wire was inserted into the renal collecting system.A 12/14 Fr ureteral access sheath (Cook Urological, USA) was inserted into the proximal ureter along the guide wire under fluo guiadnce. The Olympus URF-P5 flexible ureteroscope was then advanced via the ureteral access sheath. Irrigation was delivered by manual injection with a 50-mL syringe to achieve a relatively uniform perfusion pressure. Stones were identified and fragmented by holmium: YAG laser lithotripsy. Stone fragments were picked out by the stone basket. Tiny dust and residual fragments < 2 mm were left in place for spontaneous passage. A pigtail 6 Fr Double-J stent was routinely placed at the end of the procedure. The operative time was defined as the time from insertion of an endoscope into the urethra to the completion of stent placement.
Data collection:
Data for the three groups -age, sex, body mass index, laterality of the stone ( left or right), stone surface, stone type (single or multiple), preoperative serum creatinine level, history of hypertension,history of previous surgery, grade of hydronephrosis, operation time, irrigation volume, postoperative serum creatinine level, hemoglobin decrease, duration of hospital stay, initial stone free rate (SFR), final SFR at 1 month, SIRS and hematuresis (modified Clavine system) were recorded.
The stone surface area was measured using computerized systems either on KUB or CT scans. Hospital stay was calculated from operation to discharge from hospital. The operative time was defined as the time from insertion of an endoscope into the urethra to the completion of stent placement. Postoperative SIRS was confirmed by the follow-up 4 weeks after the operation. Stone analysis was performed using infrared spectroscopy. Stone composition was classified according to the European Association of Urology (EAU) guidelines 2015. The JJ stent was removed as an outpatient procedure at 2~4 weeks postoperatively. Postoperative follow-up with a KUB and ultrasound was scheduled at the same time. No observed fragments or fragments smaller than 2 mm was classified as stone free. Complications of all patients were recorded according to the modified Clavien classification system.
The primary endpoints of the study were postoperative SIRS. Secondary endpoints included SFR, operative time, hemoglobin drop and hematuresis.
- Conditions
- Kidney Stones
- Being tested
- Multiple-dose of Ciprofloxacin prophylaxis, Single-dose of Ciprofloxacin prophylaxis, Zero-dose of Ciprofloxacin prophylaxis
- Keywords
- kidney stones, retrograde intrarenal surgery, ciprofloxacin, prophylaxis, systemic inflammatory response syndrome
- Medical subject headings
- Kidney Calculi, Systemic Inflammatory Response Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Multiple-dose of Ciprofloxacin prophylaxisDrug
Also called Multiple-dose
Multiple-dose prophylactic antibiotic of 200mg intravenous ciprofloxacin, 30 minutes before surgery and within 12 hours after surgery additionally
Single-dose of Ciprofloxacin prophylaxisDrug
Also called Single-dose
Single-dose prophylactic antibiotic of 200mg intravenous ciprofloxacin, 30 minutes before surgery only.
Zero-dose of Ciprofloxacin prophylaxisDrug
Also called Zero-dose
Zero-dose of ciprofloxacin prophylaxis with none intravenous ciprofloxacin either preoperatively or postoperatively
| Study group | Role | What they receive |
|---|---|---|
| Multiple-dose of ciprofloxacin prophylaxis | Active comparator | Multiple-dose prophylactic antibiotic of 200mg intravenous ciprofloxacin, 30 minutes before surgery and within 12 hours after surgery additionally Receives: Drug: Multiple-dose of Ciprofloxacin prophylaxis |
| Single-dose of ciprofloxacin prophylaxis | Experimental | Single-dose prophylactic antibiotic of 200mg intravenous ciprofloxacin, 30 minutes before surgery only Receives: Drug: Single-dose of Ciprofloxacin prophylaxis |
| Zero-dose of ciprofloxacin prophylaxis | Experimental | Zero-dose of ciprofloxacin prophylaxis with none intravenous ciprofloxacin either preoperatively or postoperatively Receives: Drug: Zero-dose of Ciprofloxacin prophylaxis |
What is being measured
The primary outcome is the main question the study is designed to answer.
Postoperative SIRS
White blood count < 4000 or >12000 cells/mm3, heart rate >90 beats per minute, temperature <36°C or >38°C, respiratory rate > 20 breaths/min. Presence of two or more of these criteria was accepted as SIRS.
Measured: 4 weeks after RIRS
Secondary outcomes (5)
Stone free rate
No observed fragments or fragments smaller than 2 mm was classified as stone free.
Measured: 4 weeks after RIRS
Hemoglobin drop
Hemoglobin drop is assessed by comparing the preoperative hemoglobin level with postoperative hemoglobin level which was detected within 24-hour after RIRS.
Measured: Within 24 hours after RIRS
Postopeartive hospital stay
Hospital stay was calculated from operation to discharge from hospital.
Measured: During the hospitalization
Operative time
The operative time was defined as the time from insertion of an endoscope into the urethra to the completion of stent placement.
Measured: intraoperatively
Hematuresis
Macroscopic hematuria was observed.
Measured: 4 weeks after RIRS
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Dec 2014 (estimated)
- Study startAug 2014
- Primary completionDec 2017 (estimated)
- Study completionDec 2017 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Kidney StonesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Participant, Care provider, Outcomes assessor
- Enrolment
- 450 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Guohua Zeng
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Guohua Zeng, The First Affiliated Hospital of Guangzhou Medical University
- Investigators
- Guohua Zeng, PH.D and M.D, Study chair, The First Affiliated Hospital of Guangzhou Medical University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02304822
- Sponsor's protocol ID
- MRER(32)2014
- Acronym
- RIRS
- Status last verified
- Apr 2017
- First submitted
- 24 Nov 2014
- Last updated
- 13 Apr 2017
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Zhao Z, Fan J, Sun H, Zhong W, Zhu W, Liu Y, Wu W, de la Rosette J, Del Pilar Laguna Pes M, Zeng G. Recommended antibiotic prophylaxis regimen in retrograde intrarenal surgery: evidence from a randomised controlled trial. BJU Int. 2019 Sep;124(3):496-503. doi: 10.1111/bju.14832. Epub 2019 Jun 20.
PubMed 31136070
Study at a glance
From the registry record, last updated by the sponsor on 13 Apr 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Ciprofloxacin Prophylaxis in Retrograde Intrarenal Surgery: a Prospective Randomized Trail in Comparison of Multiple-, Single- and Zero-dose.
- ClinicalTrials.gov ID
- NCT02304822
- Acronym / sponsor ID
- RIRS / MRER(32)2014
- Conditions
- Kidney Stones
- Keywords
- kidney stones, retrograde intrarenal surgery, ciprofloxacin, prophylaxis, systemic inflammatory response syndrome
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 450 participants (estimated)
- Lead sponsor
- Guohua ZengUniversity, hospital or other
- Study start
- Aug 2014 (actual)
- Primary completion
- Dec 2017 (estimated)
- Study completion
- Dec 2017 (estimated)
- First posted
- 2 Dec 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to compare the postoperative systemic inflammatory response syndrome (SIRS) rates undergoing retrograde intrarenal surgery (RIRS) after multiple-, single-, zero-dose of ceftriaxone prophylaxis in a prospective randomized trail.
The investigators will enroll 450 patients who are candidates for RIRS in the investigators study. By simple random sampling technique, patients will be assigned to three groups (multiple-, single-, zero-dose of ceftriaxone prophylaxis,respectively). In addition to the difference of usage of ciprofloxacin prophylaxis, the rest of the procedure is the same in all three groups.The end point of the study is the comparison of outcome of procedure including SIRS rate, stone free rate (SFR), operation time, length of stay,and hematuresis.
Detailed description
PURPOSE:
To compare multiple-, single-, zero-dose antibiotic prophylaxis for retrograde intrarenal surgery (RIRS) and detect the ideal regimen to prevent systemic inflammatory response syndrome (SIRS).
METHODS:
An α error of 5% and a power of 80% were assumed to detect a 14.9% difference in rates of postoperative SIRS (5.1% for the antibiotic prophylaxis group and 20% for the control group) based on the historical data. According to sample size calculation formula for comparing rates between multiple independent samples, n=2λ/(2sin-1√Pmax-2sin-1√Pmin)2,the minimum sample sizes to detect statistically significant differences were estimated to be 86 patients for each of the study groups. To account for patients lost to follow-up and study withdrawals, this number was increased to 100.
After finishing the cases mentioned above, we find the difference in rates of postoperative SIRS in our center is 7.9% (1.2% for the antibiotic prophylaxis group and 9.1% for the control group). According to sample size calculation formula, the minimum sample sizes were estimated to be 124, additional 38 patients are required to be added to each group. For the accuracy and availability of the trial, we decided to enlarge the sample size.To account for patients lost to follow-up and study withdrawals, this number was increased to 150.
After obtaining informed consent, the patients were assessed for eligibility. To allocate the patients, a computer-generated list of random numbers was used. The patients were randomly allocated into three groups by using a randomization ratio of 1:1:1 (group 1, multiple-dose prophylactic antibiotic of 200mg intravenous ciprofloxacin, 30 minutes before surgery and within 12 hours after surgery additionally; group 2, single-dose prophylactic antibiotic of 200mg intravenous ciprofloxacin, 30 minutes before surgery; group 3,zero-dose of prophylactic antibiotic). All patients were operated under intrathecal general anesthesia.
All operations were performed by one experienced surgeon (Guohua Zeng). The surgeon was blinded to group assignment. The postoperative clinical assessment was performed by investigators who had not been involved and were also blind of the group assignment.
Preoperative routine physical examination was performed in all patients. White blood count, blood urea nitrogen, creatinine, liver function test, urinalysis, and urine culture were investigated. Before surgery, stone size and location were determined by choosing at least one of following imaging methods: intravenous pyelography (IVP), kidney, ureter, and bladder (KUB),or unenhanced CT. Inclusion Criteria and exclusion Criteria were shown in the part of "eligibility Criteria".
All equipment used during operation was chosen from the same brand, and standard sterilization procedures were applied. In this study, the investigators used SIRS criteria defined by the committee for consensus on the definition of sepsis, in order to define postoperative fever in a better way. Patients were followed postoperatively according to SIRS criteria: white blood count < 4000 or >12000 cells/mm3, heart rate >90 beats per minute, temperature <36°C or >38°C, respiratory rate > 20 breaths/min. Presence of two or more of these criteria was accepted as SIRS.
RIRS technique :All the endourological procedures in the present study were performed in a standard suite, and a sterile technique was strictly practiced and maintained in all cases. All RIRS procedures were performed under general anesthesia in a low lithotomy position. Ureteroscopy was performed with a semi-rigid 8/9.8Fr ureteroscope (Richard Wolf, Germany), and a flexible 0.035-inch guide wire was inserted into the renal collecting system.A 12/14 Fr ureteral access sheath (Cook Urological, USA) was inserted into the proximal ureter along the guide wire under fluo guiadnce. The Olympus URF-P5 flexible ureteroscope was then advanced via the ureteral access sheath. Irrigation was delivered by manual injection with a 50-mL syringe to achieve a relatively uniform perfusion pressure. Stones were identified and fragmented by holmium: YAG laser lithotripsy. Stone fragments were picked out by the stone basket. Tiny dust and residual fragments < 2 mm were left in place for spontaneous passage. A pigtail 6 Fr Double-J stent was routinely placed at the end of the procedure. The operative time was defined as the time from insertion of an endoscope into the urethra to the completion of stent placement.
Data collection:
Data for the three groups -age, sex, body mass index, laterality of the stone ( left or right), stone surface, stone type (single or multiple), preoperative serum creatinine level, history of hypertension,history of previous surgery, grade of hydronephrosis, operation time, irrigation volume, postoperative serum creatinine level, hemoglobin decrease, duration of hospital stay, initial stone free rate (SFR), final SFR at 1 month, SIRS and hematuresis (modified Clavine system) were recorded.
The stone surface area was measured using computerized systems either on KUB or CT scans. Hospital stay was calculated from operation to discharge from hospital. The operative time was defined as the time from insertion of an endoscope into the urethra to the completion of stent placement. Postoperative SIRS was confirmed by the follow-up 4 weeks after the operation. Stone analysis was performed using infrared spectroscopy. Stone composition was classified according to the European Association of Urology (EAU) guidelines 2015. The JJ stent was removed as an outpatient procedure at 2~4 weeks postoperatively. Postoperative follow-up with a KUB and ultrasound was scheduled at the same time. No observed fragments or fragments smaller than 2 mm was classified as stone free. Complications of all patients were recorded according to the modified Clavien classification system.
The primary endpoints of the study were postoperative SIRS. Secondary endpoints included SFR, operative time, hemoglobin drop and hematuresis.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, care provider, outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Multiple-dose of ciprofloxacin prophylaxis | Active comparator | Drug: Multiple-dose of Ciprofloxacin prophylaxisMultiple-dose prophylactic antibiotic of 200mg intravenous ciprofloxacin, 30 minutes before surgery and within 12 hours after surgery additionally |
| Single-dose of ciprofloxacin prophylaxis | Experimental | Drug: Single-dose of Ciprofloxacin prophylaxisSingle-dose prophylactic antibiotic of 200mg intravenous ciprofloxacin, 30 minutes before surgery only |
| Zero-dose of ciprofloxacin prophylaxis | Experimental | Drug: Zero-dose of Ciprofloxacin prophylaxisZero-dose of ciprofloxacin prophylaxis with none intravenous ciprofloxacin either preoperatively or postoperatively |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Decision to performed RIRS to treat the kidney stones
- American society of Anesthesiology (ASA) score 1 and 2
- Kidney stones of diameter < 2.5 cm
Key exclusion criteria (9 listed)
- Positive preoperative urine culture
- Pyruria (>10 white blood cells per high-power field)
- Antibiotics treatment of UTI in the last 4 weeks
- Immunocompromised
- Diabetes mellitus
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Multiple-dose of Ciprofloxacin prophylaxisAlso: Multiple-doseMultiple-dose prophylactic antibiotic of 200mg intravenous ciprofloxacin, 30 minutes before surgery and within 12 hours after surgery additionally | Drug | Multiple-dose of ciprofloxacin prophylaxis |
| Single-dose of Ciprofloxacin prophylaxisAlso: Single-doseSingle-dose prophylactic antibiotic of 200mg intravenous ciprofloxacin, 30 minutes before surgery only. | Drug | Single-dose of ciprofloxacin prophylaxis |
| Zero-dose of Ciprofloxacin prophylaxisAlso: Zero-doseZero-dose of ciprofloxacin prophylaxis with none intravenous ciprofloxacin either preoperatively or postoperatively | Drug | Zero-dose of ciprofloxacin prophylaxis |
Primary outcome
Postoperative SIRS
Time frame: 4 weeks after RIRS
White blood count < 4000 or >12000 cells/mm3, heart rate >90 beats per minute, temperature <36°C or >38°C, respiratory rate > 20 breaths/min. Presence of two or more of these criteria was accepted as SIRS.
5 secondary outcomes
Stone free rate
Time frame: 4 weeks after RIRS
Hemoglobin drop
Time frame: Within 24 hours after RIRS
Postopeartive hospital stay
Time frame: During the hospitalization
Operative time
Time frame: intraoperatively
Hematuresis
Time frame: 4 weeks after RIRS
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Apr 2017.
- Derived from this study: PubMed 31136070Zhao Z, Fan J, Sun H, Zhong W, Zhu W, Liu Y, Wu W, de la Rosette J, Del Pilar Laguna Pes M, Zeng G. Recommended antibiotic prophylaxis regimen in retrograde intrarenal surgery: evidence from a randomised controlled trial. BJU Int. 2019 Sep;124(3):496-503. doi: 10.1111/bju.14832. Epub 2019 Jun 20.
Related trials for Kidney Stones
Not yet recruiting
Automated Versus Manual Irrigation During Flexible Ureteroscopy
Renal Stone Disease
Not yet recruiting
Optimal Intrarenal Pressure During Flexible Ureteroscopy
Renal Stone Disease
RecruitingObservational study
Stone Clearance With Aspiration vs Other Technologies: a Real-world Evidence Study
Urolithiasis, Stones, Kidney
Not yet recruiting
Intertransverse Process Block Versus Erector Spinae Plane Block for Postoperative Analgesia After Percutaneous Nephrolithotomy
Kidney Stones, Urolithiasis, Hypocitraturia, Pain, Postoperative
Not yet recruiting
Comparison of Smart Pressure-Controlled Flexible Ureteroscopy and Flexible Suction Ureteral Access Sheath-Assisted Flexible Ureteroscopy for 2-3 cm Renal Stones
Kidney Stones
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Guohua Zeng, PH.D and M.D study chair
The First Affiliated Hospital of Guangzhou Medical University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Multiple-dose of Ciprofloxacin prophylaxis, Single-dose of Ciprofloxacin prophylaxis and Zero-dose of Ciprofloxacin prophylaxis in people with Kidney Stones, run by Guohua Zeng at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 13 Apr 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Guohua Zeng, PH.D and M.D (+86-13802916676, gzgyzgh@vip.tom.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Postoperative SIRS (time frame: 4 weeks after RIRS). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02304822, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2017.